Source comparison
The Mechanism Gap: Suppression vs Regeneration
Cortisone injections work by binding to glucocorticoid receptors in immune cells, downregulating pro-inflammatory cytokines (IL-1, IL-6, TNF-alpha) and reducing vascular permeability at the injection site. This suppresses the inflammatory response. The redness
This comparison does not assign a generated winner or score.
- Cortisone injections work by binding to glucocorticoid receptors in immune cells, downregulating pro-inflammatory cytokines (IL-1, IL-6, TNF-alpha) and reducing vascular permeability at the injection site. This suppresses the inflammatory response. The redness, swelling, and pain that typically follow tissue injury. The effect peaks within 48–72 hours and lasts anywhere from two weeks to three months depending on the corticosteroid half-life (methylprednisolone acetate: 12–36 hours; triamcinolone acetonide: 18–36 hours; betamethasone: up to 36 hours).
- BPC-157 differs from cortisone injections at the cellular level. It acts as a stable peptide sequence (15 amino acids) that doesn't bind to steroid receptors at all. Instead, it upregulates growth factor expression. Specifically VEGF (vascular endothelial growth factor) and bFGF (basic fibroblast growth factor). Which triggers angiogenesis in hypoxic tissue. More blood vessels mean more oxygen, nutrients, and immune signaling molecules reaching the damaged area. The peptide also promotes fibroblast proliferation, the cells responsible for laying down new collagen during the repair phase. A 2020 study in the Journal of Physiology and Pharmacology demonstrated that BPC-157 accelerated Achilles tendon healing in rat models by increasing collagen I and III deposition while reducing fibrosis.
- The practical difference: cortisone relieves pain by stopping the body's inflammatory signals. BPC-157 accelerates the repair process those signals were attempting to initiate. One is symptom management. The other is structural healing.